NDC 68151-4145

ATACAND

Candesartan Cilexetil

ATACAND is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Candesartan Cilexetil.

Product ID68151-4145_b8993a7c-905c-4b73-97d4-c46fd26b01b0
NDC68151-4145
Product TypeHuman Prescription Drug
Proprietary NameATACAND
Generic NameCandesartan Cilexetil
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1998-09-14
Marketing CategoryNDA / NDA
Application NumberNDA020838
Labeler NameCarilion Materials Management
Substance NameCANDESARTAN CILEXETIL
Active Ingredient Strength4 mg/1
Pharm ClassesAngiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 68151-4145-3

1 TABLET in 1 PACKAGE (68151-4145-3)
Marketing Start Date1998-09-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68151-4145-3 [68151414503]

ATACAND TABLET
Marketing CategoryNDA
Application NumberNDA020838
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1998-09-14
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
CANDESARTAN CILEXETIL4 mg/1

OpenFDA Data

SPL SET ID:d0c94743-cb17-4581-962e-7add11ae52e7
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 577785
  • 153822

    • Pharmacological Class

    • Angiotensin 2 Receptor Antagonists [MoA]
    • Angiotensin 2 Receptor Blocker [EPC]

    NDC Crossover Matching brand name "ATACAND" or generic name "Candesartan Cilexetil"

    NDCBrand NameGeneric Name
    0186-0004ATACANDCandesartan cilexetil
    0186-0008ATACANDCandesartan cilexetil
    0186-0016ATACANDCandesartan cilexetil
    0186-0032ATACANDCandesartan cilexetil
    68151-4146ATACANDATACAND
    68151-4145ATACANDATACAND
    62559-643ATACANDATACAND
    62559-641ATACANDATACAND
    62559-642ATACANDATACAND
    62559-640ATACANDATACAND
    63629-3376ATACANDATACAND
    0378-3224candesartan cilexetilcandesartan cilexetil
    0378-3225candesartan cilexetilcandesartan cilexetil
    0378-3231candesartan cilexetilcandesartan cilexetil
    0378-3232candesartan cilexetilcandesartan cilexetil
    0781-5936Candesartan cilexetilCandesartan cilexetil
    0781-5937Candesartan cilexetilCandesartan cilexetil
    0781-5938Candesartan cilexetilCandesartan cilexetil
    0781-5939Candesartan cilexetilCandesartan cilexetil
    46708-060CANDESARTAN CILEXETILCANDESARTAN CILEXETIL
    46708-341CANDESARTAN CILEXETILCANDESARTAN CILEXETIL
    46708-342CANDESARTAN CILEXETILCANDESARTAN CILEXETIL
    46708-343CANDESARTAN CILEXETILCANDESARTAN CILEXETIL
    49884-658Candesartan cilexetilCandesartan cilexetil
    49884-659Candesartan cilexetilCandesartan cilexetil
    49884-660Candesartan cilexetilCandesartan cilexetil
    49884-661Candesartan cilexetilCandesartan cilexetil
    60687-119Candesartan cilexetilCandesartan cilexetil
    60687-130Candesartan cilexetilCandesartan cilexetil
    60687-241Candesartan cilexetilCandesartan cilexetil

    Trademark Results [ATACAND]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ATACAND
    ATACAND
    75477028 not registered Dead/Abandoned
    ASTRA AB
    1998-04-30
    ATACAND
    ATACAND
    75033908 2160791 Live/Registered
    AstraZeneca AB
    1995-12-18
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.